These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11851721)

  • 21. Association of
    Godbole C; Thaker S; Kerkar P; Nadkar M; Gogtay N; Thatte U
    Future Cardiol; 2021 Jan; 17(1):119-126. PubMed ID: 32583675
    [No Abstract]   [Full Text] [Related]  

  • 22. Paraoxonase-1 L55M polymorphism is associated with an abnormal oral glucose tolerance test and differentiates high risk coronary disease families.
    Deakin S; Leviev I; Nicaud V; Brulhart Meynet MC; Tiret L; James RW;
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1268-73. PubMed ID: 11889198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance.
    Hussein YM; Gharib AF; Etewa RL; ElSawy WH
    Mol Cell Biochem; 2011 May; 351(1-2):117-23. PubMed ID: 21229382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variations of the paraoxonase gene in patients with coronary artery disease.
    Hong SH; Song J; Min WK; Kim JQ
    Clin Biochem; 2001 Sep; 34(6):475-81. PubMed ID: 11676977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of
    Rahman N; Zakiullah ; Jan A; Saeed M; Khan MA; Parveen Z; Iqbal J; Ali S; Shah WA; Akbar R; Khuda F
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
    Ozkök E; Aydin M; Babalik E; Ozbek Z; Ince N; Kara I
    Med Sci Monit; 2008 Oct; 14(10):CR536-42. PubMed ID: 18830194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.
    Birjmohun RS; Vergeer M; Stroes ES; Sandhu MS; Ricketts SL; Tanck MW; Wareham NJ; Jukema JW; Kastelein JJ; Khaw KT; Boekholdt SM
    PLoS One; 2009 Aug; 4(8):e6809. PubMed ID: 19710913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of paraoxonase1 gene Q192R polymorphism and apolipoprotein B in Asian Indian women with coronary artery disease risk.
    Deshpande CS; Singhal RS; Mukherjee MS
    Genet Test Mol Biomarkers; 2013 Feb; 17(2):140-6. PubMed ID: 23171143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PON1 polymorphisms are predictors of ability to attain HDL-C goals in statin-treated patients.
    de Souza JA; Menin A; Lima LO; Smiderle L; Hutz MH; Van Der Sand CR; Van Der Sand LC; Ferreira ME; Pires RC; Almeida S; Fiegenbaum M
    Clin Biochem; 2015 Nov; 48(16-17):1039-44. PubMed ID: 26079344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Smoking enhances the decrease of adiponectin level in patients with coronary artery disease, carriers of MTHFR 677T and PON1 55M alleles].
    Strauss E; Radziemski A; Głuszek J; Pawlak A
    Przegl Lek; 2010; 67(10):859-65. PubMed ID: 21360915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
    Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M
    Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paraoxonase 1 (PON1) L55M and Q192R polymorphisms are not associated with chronic kidney disease in Thai individuals with type 2 diabetes.
    Nawaka N; Pansang P; Saniwa A; Chaibut N; Jeenduang N
    Int J Clin Pract; 2021 Dec; 75(12):e14982. PubMed ID: 34637171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraoxonase-1 Q192R polymorphism and its association with hs-CRP and fasting blood glucose levels and risk of coronary artery disease.
    Amini M; Esmaeilzadeh-Bahabadi S; Avan A; Gholoobi A; Ghasemi F; Mirhafez SR; Ghazizadeh H; Moohebati M; Ebrahimi M; Ferns GA; Pasdar A; Mobarhan MG
    Diabetes Metab Syndr; 2019; 13(2):1053-1057. PubMed ID: 31336443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between PON1L55M and Q192R gene polymorphisms and high APO B/APO A-I ratios.
    Khoshi A; Mortazavi Y; Akbari A; Sokhanvar S; Kalantari S
    Indian J Clin Biochem; 2009 Oct; 24(4):381-7. PubMed ID: 23105865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
    Lacinski M; Skorupski W; Cieslinski A; Sokolowska J; Trzeciak WH; Jakubowski H
    Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):885-93. PubMed ID: 15704252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan.
    Ko YL; Ko YS; Wang SM; Hsu LA; Chang CJ; Chu PH; Cheng NJ; Chen WJ; Chiang CW; Lee YS
    Atherosclerosis; 1998 Dec; 141(2):259-64. PubMed ID: 9862174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease].
    Taşkiran P; Cam SF; Sekuri C; Tüzün N; Alioğlu E; Altintaş N; Berdeli A
    Turk Kardiyol Dern Ars; 2009 Oct; 37(7):473-8. PubMed ID: 20098041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.
    Pfohl M; Koch M; Enderle MD; Kühn R; Füllhase J; Karsch KR; Häring HU
    Diabetes; 1999 Mar; 48(3):623-7. PubMed ID: 10078566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Q192R polymorphism of the paraoxonase-1 gene as a risk factor for obesity in Portuguese women.
    Veiga L; Silva-Nunes J; Melão A; Oliveira A; Duarte L; Brito M
    Eur J Endocrinol; 2011 Feb; 164(2):213-8. PubMed ID: 21078685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do PON1-Q192R and PON1-L55M polymorphisms modify the effects of hypoxic training on paraoxonase and arylesterase activity?
    Yigittürk O; Turgay F; Kızıldağ S; Özsoylu D; Balcı GA
    J Sport Health Sci; 2023 Mar; 12(2):266-274. PubMed ID: 33188964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.